CBS News
@CBSNews·7M subscribers·153.5K videos
Pharmaceutical giant shipped investigational coronavirus drug to China without U.S. approval
Posted
March 9, 2020
Views
32,788
Likes
238
Comments
115
Engagement
March 9, 2020
32,788
238
115
1.08%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
5:03Now PlayingPharmaceutical giant Gilead reportedly sent a batch of an investigational coronavirus drug to China, without U.S. government approval. The company may have violated federal law by shipping the drug without the go-ahead from department of Health of Human Services officials. Axios reporter Caitlin Owens joins CBSN to discuss.
Subscribe to the CBS News Channel HERE
Watch CBSN live HERE
Follow CBS News on Instagram HERE
Like CBS News on Facebook HERE
Follow CBS News on Twitter HERE
Get the latest news and best in original reporting from CBS News delivered to your inbox. Subscribe to newsletters HERE
Get your news on the go! Download CBS News mobile apps HERE
Get new episodes of shows you love across devices the next day, stream CBSN and local news live, and watch full seasons of CBS fan favorites like Star Trek Discovery anytime, anywhere with CBS All Access. Try it free!
---
CBSN is the first digital streaming news network that will allow Internet-connected consumers to watch live, anchored news coverage on their connected TV and other devices. At launch, the network is available 24/7 and makes all of the resources of CBS News available directly on digital platforms with live, anchored coverage 15 hours each weekday. CBSN. Always On.
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
